Skip to content
Screener

Nutex Health Inc. NUTX Q2 2025 earnings

Reported October 8, 2025 · After market close

Revenue$244.0MBeat by $22.1M
EPS-$3.02Beat by $2.41
Revenue estimate$221.9M
EPS estimate-$5.43

Next report

Nov 17, 2026 (in 2 months)
Revenue estimate$215.0M
EPS estimate$5.71

Financials

Q2 2025

Income statement

See full
Revenue$244.0M+221%
Gross profit$124.9M+454%
Operating income$33.7M+536%
Net income-$17.7M-4,762%
EPS (diluted)-$2.95-4,114%

Balance sheet

See full
Cash & equivalents$96.7M+137%
Total debt$337.4M+18.1%
Total equity$235.3M+275%
Total assets$841.0M+99.1%

Cash flow

See full
Operating cash flow$27.3M+106%
CapEx$751.0K+34.3%
Free cash flow$26.5M+109%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$640.73M+2,066%
Enterprise value$881.38M+221%
P/E11.4×—
P/S0.8×+0.7×

Profitability

See full
Gross margin51.4%+32.1pp
Operating margin30.1%+25.1pp
Net margin7.1%+4.3pp
FCF margin10.6%+5.8pp

Returns & leverage

See full
Return on equity37.9%+24.2pp
Debt / equity1.4×-3.1×
Current ratio2.4×+0.8×

Segments

By segment

See full
Real estate division$824.0K+519%

FAQ

When did Nutex Health Inc. report Q2 2025 earnings?
Nutex Health Inc. (NUTX) reported Q2 2025 earnings on October 8, 2025 after market close.
What were Nutex Health Inc.'s Q2 2025 revenue and EPS?
Nutex Health Inc. reported revenue of $244.0M and eps of $-3.02 for Q2 2025.
Did Nutex Health Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $221.9M by $22.1M. EPS beat the consensus estimate of $-5.43 by $2.41.
How did Nutex Health Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 220.7% from $76.1M a year earlier and eps declined 4219.4% from $-0.07.